Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipid Metabolism, Inborn Errors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02489344
What this trial is testing

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 8
Not applicableStudy completedNCT04281537
What this trial is testing

Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

Who this might be right for
Fabry Disease
Amicus Therapeutics 82
Large-scale testing (Phase 3)Study completedNCT00289900
What this trial is testing

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Who this might be right for
Mixed Hyperlipidemia
Merck Sharp & Dohme LLC 2,340
Not applicableUnknownNCT02489253
What this trial is testing

Atherosclerosis in Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
University College, London 100
Not applicableStudy completedNCT01971957
What this trial is testing

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers

Who this might be right for
Sjogren-Larsson Syndrome (SLS)
University of Nebraska 20
Not applicableStudy completedNCT04708301
What this trial is testing

Characterisation of Heart Involvement in Fabry Disease With T1 Mapping

Who this might be right for
Fabry Disease
Manchester University NHS Foundation Trust 200
Not applicableStudy completedNCT00414583
What this trial is testing

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

Who this might be right for
Cerebrovascular Accident
CENTOGENE GmbH Rostock 5,000
Testing effectiveness (Phase 2)Study completedNCT01304277
What this trial is testing

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

Who this might be right for
Fabry Disease
Shire 17
Not applicableStudy completedNCT01439607
What this trial is testing

Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells in Gaucher Disease

Who this might be right for
Gaucher Disease
Assistance Publique - Hôpitaux de Paris 30
Not applicableWithdrawnNCT04056000
What this trial is testing

Lipodystrophy and Fat Metabolism During Exercise

Who this might be right for
HealthyLipodystrophy, Familial Partial
University of Exeter
Not applicableUnknownNCT00871611
What this trial is testing

Viennese Prevalence Study of Anderson-Fabry Disease

Who this might be right for
Fabry DiseaseLeft Ventricular Hypertrophy
Medical University of Vienna 4,000
Early research (Phase 1)Study completedNCT01505998
What this trial is testing

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

Who this might be right for
Fed
Dr. Reddy's Laboratories Limited 49
Not applicableLooking for participantsNCT07382128
What this trial is testing

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Who this might be right for
HCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseCardiac Magnetic Resonance Imaging+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250
Large-scale testing (Phase 3)Ended earlyNCT04840667
What this trial is testing

Replagal in Treatment-naïve Adults With Fabry Disease

Who this might be right for
Fabry Disease
Shire 17
Not applicableStudy completedNCT02719249
What this trial is testing

Fabry Disease Screening in ESRD Patients in West of France

Who this might be right for
ESRD
Rennes University Hospital 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07473843
What this trial is testing

Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia

Who this might be right for
Homozygous Familial Hypercholesterolemia
Arrowhead Pharmaceuticals 12
Early research (Phase 1)Study completedNCT01427517
What this trial is testing

Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease

Who this might be right for
Parkinson's DiseaseGaucher's Disease
University of Minnesota 9
Large-scale testing (Phase 3)Ended earlyNCT02527343
What this trial is testing

The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 40
Large-scale testing (Phase 3)WithdrawnNCT02921620
What this trial is testing

Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease

Who this might be right for
Fabry Disease
Protalix
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Next Page